RESULTS OF TOPICAL TREATMENT BY E-PSORA (PHA, JOJOBA OIL, VITAMIN E) OF PLAQUE PSORIASIS AT CAN THO DERMATO- VENEREOLOGY HOSPITAL AND CAN THO UNIVERSITY OF MEDICINE AND PHARMACY HOSPITAL IN 2019-2021

Thi Thao My Nguyen1, , Van Ba Huynh1
1 Can Tho University of Medicine and Pharmacy

Main Article Content

Abstract

Background: Psoriasis affects an estimated 2% of the world's population.. E-PSORA contains PHA, jojoba oil, and vitamin E with antioxidant, anti-inflammatory and moisturizing propertie which have potential benefits in topical psoriasis treatment. Objectives: evaluate results of topical treatment of plaque psoriasis at Can Tho Dermato-Venereology Hospital and Can Tho University of Medicine and Pharmacy Hospital in 2019-2021. Materials and methods: A descriptive cross-sectional study was conducted on 155 mild and moderate plaque psoriasis, treatment duration with E-PSORA for 6 weeks. Results: very good results had level 3.9%, good had level 32.9%, quite had level 38.1%, medium had level 20.0% and poor results had level 5.2%. Side effects only recorded 5.8% itching and 7.1% skin redness in the first week, which disappeared in the next 5 weeks of treatment. Conclusion: E-PSORA is an effective topical therapy in reducing psoriatic lesions with few side effects.

Article Details

References

1. Hội Da Liễu Việt Nam (2016), Hướng dẫn chăm sóc và điều trị bệnh vảy nến, Nhà xuất bản y học, Hà Nội.
2. Vũ Linh Thành, 2017. Phân tích tình hình sử dụng acid salicylic tại Bệnh viện Da liễu Trung ương. Luận văn dược sĩ đại học. Đại Học Quốc Gia Hà Nội. Hà Nội.
3. Trương Lê Anh Tuấn và Lê Ngọc Diệp, 2012. Mối liên quan giữa bệnh vảy nến và hội chứng chuyển hóa. Tạp chí Y học TP.Hồ Chí Minh. 16 (1/2012):268-271.
4. Akamine, K. L. et al, 2013. A double-blind, randomized clinical trial of 20% alpha/poly hydroxy acid cream to reduce scaling of lesions associated with moderate, chronic plaque psoriasis. J Drugs Dermatol. 12(8): 855-9.
5. Chularojanamontri, et al, 2014. A Guide to the Ingredients of Over-the-Counter Moisturizers for Psoriasis. S sage journals. 20(1): 24-30.
6. Fredriksson, T and Pettersson, U (1978), "Severe psoriasis–oral therapy with a new retinoid", Dermatology. 157(4), pp. 238-244.
7. Mease, P. J and Armstrong, A. W., 2020. Pathophysiology, Clinical Presentation, and Treatment of Psoriasis: A Review. Jama. 323(19): 1945-1960.
8. Pazyar, N and Yaghoobi, R, 2016. The Potential Anti-Psoriatic Effects of Jojoba Extract. Journal of Dermatological Research. 1(1): 14-15.
9. Prignano, F., et al. (2009), "Itch in psoriasis: epidemiology, clinical aspects and treatment options", Clin Cosmet Investig Dermatol. 2, pp. 9-13.
10. Sarafian, G. et al, 2015.Topical Turmeric Microemulgel in the Management of Plaque Psoriasis; A Clinical Evaluation. Iran J Pharm Res. 14(3): 865-76.
11. Shiri, J. C, Assi, A. C, Arnon D, 2011. An open-label study of herbal topical medication (Psirelax) for patients with chronic plaque psoriasis. Science World Journal. 6(4): 13-16.